Exact Sciences Corporation (NASDAQ:EXAS) Q2 2023 Earnings Call Transcript August 1, 2023 5:00 PM ET Company Participants Megan Jones - Vice President of Investor Relations Kevin Conroy - Chairman and Chief Executive Officer Jeff Elliott - Chief Financial Officer Everett Cunningham - Chief Commercial Officer Conference Call Participants Derik de Bruin - Bank of America Catherine Schulte - Baird Vijay Kumar - Evercore ISI Dan Brennan - TD Cowen Brandon Couillard - Jefferies Patrick Donnelly - Citi Dan Arias - ...

We aim to eradicate cancer with tests that help prevent it, detect it earlier, and guide treatment. Second-quarter 2023 earnings call August 1, 2023 EXACT SCIENCES 1 Safe harbor and non-GAAP disclosures This presentation contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35092 EXACT SCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 02-0478229 (State or other jurisdiction of (I.R.S. Employer incorporation or ...

We aim to eradicate cancer with tests that help prevent it, detect it earlier, and guide treatment. First quarter 2023 earnings call May 9, 2023 EXACT SCIENCES Safe harbor and non-GAAP disclosures This presentation contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject t ...

Exact Sciences Corporation (NASDAQ:EXAS) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ET Company Participants Megan Jones - IR Kevin Conroy - Chairman & CEO Jeffrey Elliott - CFO & COO Everett Cunningham - Chief Commercial Officer Conference Call Participants Brandon Couillard - Jefferies Catherine Schulte - Baird Vijay Kumar - Evercore ISI Andrew Brackmann - William Blair Jack Meehan - Nephron Research Daniel Arias - Stifel Derik De Bruin - Bank of America Matt Sykes - Goldman Sachs Dan Brennan - C ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35092 EXACT SCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 02-0478229 (State or other jurisdiction of (I.R.S. Employer incorporation o ...

Exact Sciences Corporation (NASDAQ:EXAS) Q4 2022 Earnings Conference Call February 21, 2023 5:00 PM ET Company Participants Megan Jones - Investor Relations Kevin Conroy - Chairman and Chief Executive Officer Jeff Elliott - Chief Financial Officer and Chief Operating Officer Everett Cunningham - Chief Commercial Officer Conference Call Participants Derik De Bruin - Bank of America Andrew Brackmann - William Blair Dan Brennan - Cowen Vijay Kumar - Evercore ISI Catherine Schulte - Baird Brandon Couillard - Je ...

Making earlier cancer detection a routine part of medical care Fourth quarter 2022 earnings call February 21, 2023 EXACT SCIENCES 1 Safe harbor and non-GAAP disclosures This pre ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-35092 | --- | --- | --- | |--------------------------------------------------------- ...

Exact Sciences Corporation (NASDAQ:EXAS) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Megan Jones - Associate Manager, IR Kevin Conroy - Chairman & CEO Jeffrey Elliott - EVP, CFO & COO Everett Cunningham - Chief Commercial Officer Conference Call Participants Brandon Couillard - Jefferies Derik De Bruin - Bank of America Merrill Lynch Catherine Schulte - Robert W. Baird & Co. Jack Meehan - Nephron Research Alexander Vukasin - Canaccord Genuity Vijay Kumar - Evercore ISI ...